On World Disease Day, the entity informs about the possibility of being a brain tissue donor and thus contributing to research work
AFA demands that research in the fight against Alzheimer's be intensified
The Association of Relatives, Patients and Collaborators of Alzheimer's, AFA Marina Baixa, has called for "intensifying research" in the itinerary of dementia in order to advance in this way in the fight against the disease. This is reflected in the manifesto read today by the president of the entity, Garbiñe Mondragón, on the occasion of World Alzheimer's Day during an event held at Plaza SSMM Reyes de España. An act in which AFA Marina Baixa has been supported by the acting mayor, Ana Pellicer; the Councilor for Social Welfare, Ángela Llorca; members of the Municipal Corporation; users of the Vallesol residence; and representatives of local social entities such as AFEM, Aerbeco, Anémona and Doble Amor.
Mondragón has stressed the need to allocate more resources to all types of research: biomedical, basic, translational, clinical and socio-health; and promote access to the knowledge and results of this research to the population in general, making known the existence of the Spanish Registry of Clinical Studies (REec), which is a public database, free to use and free of charge.
Likewise, the president of AFA has taken advantage of the celebration of World Alzheimer's Day to inform about the donation of brain tissue. Mondragón explained that anyone can be a post-mortem donor of brain tissue, whether they have a neurological or psychiatric disease or a healthy person, thus contributing to the research work.
To close the event, the Councilor for Social Welfare congratulated "the staff" of AFA Marina Baixa and reminded them that "you are a respite for many families, for whom it would be very difficult to carry out this disease without you."
The reading of this manifesto has been the central act of the nineteenth Alzheimer's Week, which began on September 14 and with which each year AFA wants to make the population visible and aware of the scope of Alzheimer's and the need to redouble efforts and resources devoted to research on this disease.